A similar effect was observed in the MIAPaCa‐2 and AsPC1 human pancreatic cancer cell lines, which carry ARID1A mutations or exhibit low ARID1A expression (Figure 5C). Here, ARID1A is linked to familial pancreatic carcinoma.